Literature DB >> 20732934

Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats.

Keiko Nakahara1, Tetsuro Katayama, Keisuke Maruyama, Takanori Ida, Kenji Mori, Mikiya Miyazato, Kenji Kangawa, Noboru Murakami.   

Abstract

We compared the central mechanisms of feeding suppression by the anorexigenic hormones neuromedin U (NMU) and neuromedin S (NMS) in rats. I.c.v. injection of either NMU or NMS dose dependently decreased 3-h food intake during the first quarter of a dark period. Pretreatment involving i.c.v. injection of a specific anti-NMS IgG blocked the suppression of food intake induced by i.c.v.- and i.p.-injected leptin, but anti-NMU IgG elicited no blockade. Quantitative PCR analysis revealed that i.c.v. injection of NMU or NMS caused a dose-dependent increase in CRH and proopiomelanocortin mRNA expression in the paraventricular nucleus (PVN) and arcuate nucleus (Arc) respectively. In tissue cultures of the Arc, secretion of α-melanocyte-stimulating hormone was stimulated by NMU and NMS, with more potent stimulation by NMS. The time-course curves of the increase in neuronal firing rate in Arc slices in response to NMU and NMS showed almost the same pattern, with a peak 10-15 min after treatment, whereas the time-course curves for the PVN slices differed between NMU and NMS. These results suggest that NMS and NMU may share anorexigenic effects, depending on physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732934     DOI: 10.1677/JOE-10-0081

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Escitalopram alters local expression of noncanonical stress-related neuropeptides in the rat brain via NPS receptor signaling.

Authors:  Aneta Piwowarczyk-Nowak; Artur Pałasz; Aleksandra Suszka-Świtek; Alessandra Della Vecchia; Aniela Grajoszek; Marek Krzystanek; John J Worthington
Journal:  Pharmacol Rep       Date:  2022-06-02       Impact factor: 3.919

2.  Regulation of motivation for food by neuromedin U in the paraventricular nucleus and the dorsal raphe nucleus.

Authors:  D L McCue; J M Kasper; J D Hommel
Journal:  Int J Obes (Lond)       Date:  2016-10-17       Impact factor: 5.095

3.  Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis.

Authors:  Ludwik K Malendowicz; Agnieszka Ziolkowska; Marcin Rucinski
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-05       Impact factor: 5.555

4.  Different distribution of neuromedin S and its mRNA in the rat brain: NMS peptide is present not only in the hypothalamus as the mRNA, but also in the brainstem.

Authors:  Miwa Mori; Kenji Mori; Takanori Ida; Takahiro Sato; Masayasu Kojima; Mikiya Miyazato; Kenji Kangawa
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-03       Impact factor: 5.555

5.  Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents.

Authors:  Daniel Vallöf; Lisa Ulenius; Emil Egecioglu; Jörgen A Engel; Elisabet Jerlhag
Journal:  Addict Biol       Date:  2016-01-14       Impact factor: 4.280

Review 6.  Neuromedins NMU and NMS: An Updated Overview of Their Functions.

Authors:  Ludwik K Malendowicz; Marcin Rucinski
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.